Stocks
Emmaus Life Sciences, Inc.EMMA
OQBHealthcareBiotechnology$0.06
Price as of · delayed, not real-time
A commercial-stage biopharmaceutical company focused on developing and commercializing therapies for rare diseases, with its lead product, an oral treatment for sickle cell disease, approved in the U.S. and several other markets. Investors track the company for its commercial ramp-up and pipeline expansion in hematology and oncology.
52W Range: $0.01-$0.09
Congressional Interest in Emmaus Life Sciences, Inc. (EMMA)
No congressional trades have been disclosed for Emmaus Life Sciences, Inc. (EMMA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading EMMA?
No congressional trades found for this stock.